Utah Medical Products Inc
UTMD· Nasdaq
Released Apr 29, 2025, during market hours
10-Q filed May 15, 2025, 45 days after period end · 0001096906-25-000816
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $9.71M | $11.34M | $12.52M | $12.32M |
| Net Income | $3.04M | $3.96M | $4.21M | $3.53M |
| EPS Diluted |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $0.92 |
| $1.09 |
| $1.16 |
| $0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.